UNITED STATES ANTIMONY CORP
Business
UNITED STATES ANTIMONY CORP is principally engaged in the processing and sale of antimony and precious metals and the mining, processing, and sale of zeolite. Its primary products include antimony trisulfide, antimony oxide, antimony metal, coarse and fine zeolite, and refined and unrefined gold and silver. The company is organized into two reportable segments—an antimony segment that comprises its Montana processing facility and its USAMSA facilities in Mexico, and a zeolite segment represented by Bear River Zeolite in Idaho. It sells products to customers in the United States, Mexico, and Canada and operates processing and mining facilities in Montana, Mexico, and Idaho, with acquired mining claims in Alaska and Ontario.
Summary from filing dated 2025-03-20
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenues | 39 | 15 | — | — | — | |
| Cost of revenues | 29 | 11 | 12 | 9 | 7 | |
| Gross profit | 10 | 3 | −3 | 2 | 838,605 | |
| General and administrative | 3 | 2 | 2 | 658,242 | 677,558 | |
| Salaries and benefits | 12 | 2 | 639,172 | 481,106 | 298,506 | |
| Professional fees | 2 | 968,750 | 643,208 | 302,901 | 264,502 | |
| Loss on sale or disposal of property, plant and equipment, net | 51,350 | 11,097 | 217,921 | 0 | — | |
| Gain on lease termination | −469,822 | — | — | — | — | |
| Other operating expenses | 2 | 475,010 | 581,647 | 205,736 | — | |
| Total operating expenses | 18 | 6 | 4 | 2 | 1 | |
| Loss from operations | −8 | −2 | −7 | 348,205 | −660,257 | |
| Interest and investment income | 810,546 | 668,543 | — | — | — | |
| Unrealized gain on investment in equity securities | 3 | — | — | — | — | |
| Other miscellaneous income (expense), net | −12,693 | −8,135 | 69,945 | −39,891 | 599,788 | |
| Total other income, net | 4 | 660,408 | 720,714 | 96,529 | — | |
| Loss before income taxes | −4 | −2 | −6 | 444,734 | −60,469 | |
| Income tax expense | 0 | 0 | 0 | 16,073 | — | |
| Net loss | −4 | −2 | −6 | 428,661 | −60,469 | |
| Preferred dividends | −7,500 | −7,500 | — | — | — | |
| Net loss available to common shareholders | −4 | −2 | −6 | 381,383 | −108,663 | |
| Basic (in dollars per share) | −0.04 | −0.02 | −0.06 | — | — | |
| Diluted (in dollars per share) | −0.04 | −0.02 | −0.06 | — | — | |
| Basic (in shares) | 124 | 109 | 108 | — | — | |
| Diluted (in shares) | 124 | 109 | 108 | 106 | — |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 30 | 18 | — | — | — | |
| Investment in debt securities held to maturity | 5 | — | — | — | — | |
| Accounts receivable, net | 4 | 1 | 625,256 | 784,457 | 891,314 | |
| Inventories | 13 | 1 | 1 | 1 | — | |
| Prepaid expenses and other current assets | 434,842 | 160,954 | 92,369 | 137,599 | 0 | |
| Note receivable | 3 | — | — | — | — | |
| Total current assets | 55 | 21 | 14 | 22 | 24 | |
| Property, plant and equipment, net | 42 | 13 | 13 | 12 | 11 | |
| Operating lease right-of-use assets | 48,106 | 565,289 | 0 | — | — | |
| Investment securities held to maturity - noncurrent | 16 | — | — | — | — | |
| Investment in equity securities | 40 | — | — | — | — | |
| Restricted cash for reclamation bonds | 162,756 | 98,778 | — | — | — | |
| IVA receivable and other assets, net | 330,207 | 408,519 | 509,237 | 897,679 | 242,721 | |
| Total assets | 154 | 35 | 28 | 35 | 35 | |
| Accounts payable | 7 | 2 | 456,935 | 628,803 | 1 | |
| Accrued liabilities | 3 | 2 | 133,841 | 201,149 | 273,785 | |
| Current portion of operating lease liabilities | 34,103 | 626,562 | 0 | — | — | |
| Current portion of long-term debt | 136,942 | 132,252 | 28,443 | 94,150 | 13,230 | |
| Total current liabilities | 10 | 4 | 897,458 | 2 | 2 | |
| Operating lease liabilities, net of current portion | 14,003 | 129,007 | 0 | — | — | |
| Long-term debt, net of current portion | 58,483 | 195,425 | 0 | 217,855 | — | |
| Asset retirement obligations | 3 | 2 | 2 | 332,011 | 298,649 | |
| Total liabilities | 13 | 6 | 3 | 3 | 3 | |
| COMMITMENTS AND CONTINGENCIES (Note 4,7,13) | — | — | — | — | — | |
| Common stock, $0.01 par value, 250,000,000 shares authorized; 140,042,270 and 112,951,317 shares issued and outstanding, respectively | 1 | 1 | 1 | 1 | 1 | |
| Treasury stock (149,639 and no shares of common stock at cost, respectively) | −574,153 | — | — | — | — | |
| Additional paid-in capital | 186 | 69 | 64 | 64 | 64 | |
| Accumulated deficit | −45 | −41 | −39 | −33 | −33 | |
| Total stockholders' equity | 141 | 29 | 26 | 32 | 32 | |
| Total liabilities and stockholders' equity | 154 | 35 | 28 | 35 | 35 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net loss | −4 | −2 | −6 | 428,661 | — | |
| Depreciation and amortization | 1 | 1 | 959,445 | 909,220 | 880,880 | |
| Accretion of asset retirement obligation | 77,932 | 73,081 | 13,471 | 17,766 | 6,930 | |
| Noncash operating lease expense | 289,542 | 190,280 | 0 | — | — | |
| Share-based compensation | 7 | 568,588 | 0 | — | — | |
| Accretion income from investment in debt securities held to maturity | −416,004 | — | — | — | — | |
| Write-down of inventory to net realizable value | 919,053 | 65,647 | 2 | 277,146 | 0 | |
| Change in allowance for credit losses | −9,256 | −261,047 | −239,772 | — | — | |
| Change in IVA receivable reserve | 1 | 140,057 | 388,442 | — | — | |
| Other noncash items | — | −16,107 | −7,500 | −647 | 0 | |
| Accounts receivable | −3 | −213,468 | −80,571 | 47,507 | −652,680 | |
| Inventories | −12 | 74,738 | −2 | −596,794 | −405,207 | |
| Prepaid expenses and other current assets | −283,888 | −68,585 | 45,230 | −137,599 | 0 | |
| IVA receivable and other assets, net | −1 | −39,339 | — | — | — | |
| Accounts payable | 3 | 1 | — | — | — | |
| Accrued liabilities | 1 | 1 | −67,308 | −72,636 | 74,986 | |
| Accrued liabilities - directors | 2,644 | 16,477 | 51,847 | — | — | |
| Stock payable to directors | — | −38,542 | −22,917 | — | — | |
| Net cash (used in) provided by operating activities | −10 | 2 | −5 | −249,277 | −2 | |
| Proceeds from redemption of certificates of deposit | — | 72,898 | 186,959 | 0 | — | |
| Purchases of investment in debt securities held to maturity | −20 | — | — | — | — | |
| Purchases of equity investment securities | −37 | — | — | — | — | |
| Issuance of note receivable | −3 | — | — | — | — | |
| Proceeds from sales or disposals of property, plant and equipment | 13,366 | 315,625 | 0 | — | — | |
| Purchases of property, plant and equipment | −28 | −430,596 | −2 | −2 | −648,128 | |
| Net cash used in investing activities | −87 | −42,073 | −1 | −2 | −653,126 | |
| Principal payments on long-term debt | −132,252 | −103,488 | −283,562 | −64,745 | — | |
| Proceeds from exercises of stock options | 117,667 | — | — | — | — | |
| Acquisition of treasury stock related to equity awards | −449,475 | — | 0 | −202,980 | 0 | |
| Proceeds from issuance of common stock, net of issuance costs | 104 | 3 | 0 | — | — | |
| Proceeds from exercise of warrants | 6 | 1 | — | 0 | 2 | |
| Net cash provided by financing activities | 109 | 4 | −1 | −267,725 | 24 | |
| NET INCREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH | 12 | 6 | −7 | −2 | 21 | |
| Interest paid in cash | 16,654 | 8,869 | 10,521 | 15,141 | 5,539 | |
| Recognition of operating lease liability and right-of-use asset | 86,188 | 787,477 | — | — | — | |
| Equipment purchased with note payable | — | 402,722 | — | — | — | |
| Property and equipment included in accounts payable | 2 | — | — | — | — |